Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS One, volume 8, issue 1, e53100 (2013)
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Univ.-Bibliothek Frankfurt am Main
- (wann)
-
2013
- Beteiligte Personen und Organisationen
-
Jüngel, Eva
Makarević, Jasmina
Tsaur, Igor
Bartsch, Georg
Nelson, Karen
Haferkamp, Axel
Blaheta, Roman A.
- URN
-
urn:nbn:de:hebis:30:3-287041
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jüngel, Eva
- Makarević, Jasmina
- Tsaur, Igor
- Bartsch, Georg
- Nelson, Karen
- Haferkamp, Axel
- Blaheta, Roman A.
- Univ.-Bibliothek Frankfurt am Main
Entstanden
- 2013
Ähnliche Objekte (12)
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
Valproic acid restricts mast cell activation by Listeria monocytogenes
Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
HDAC inhibitor valproic acid increases CRABP2 expression and in combination with retinoic acid synergistically inhibits proliferation in glioblastoma cells
Influence of the HDAC inhibitor Valproic acid on the growth and proliferation of Temsirolimus-resistant prostate cancer cells in vitro
Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
Entwicklung von Klasse I/IIb Histondeacetylase (HDAC)-inhibitoren und HDAC-PROTACs
Publisher Correction: Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
Valproic acid restricts mast cell activation by Listeria monocytogenes
Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
HDAC inhibitor valproic acid increases CRABP2 expression and in combination with retinoic acid synergistically inhibits proliferation in glioblastoma cells
Influence of the HDAC inhibitor Valproic acid on the growth and proliferation of Temsirolimus-resistant prostate cancer cells in vitro
Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
Entwicklung von Klasse I/IIb Histondeacetylase (HDAC)-inhibitoren und HDAC-PROTACs
Publisher Correction: Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
Valproic acid restricts mast cell activation by Listeria monocytogenes
Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
HDAC inhibitor valproic acid increases CRABP2 expression and in combination with retinoic acid synergistically inhibits proliferation in glioblastoma cells
Influence of the HDAC inhibitor Valproic acid on the growth and proliferation of Temsirolimus-resistant prostate cancer cells in vitro
Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
Entwicklung von Klasse I/IIb Histondeacetylase (HDAC)-inhibitoren und HDAC-PROTACs
Publisher Correction: Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer